**To** 

## **Trustees' Annual Report for the period** 

Period start date Period end date 1 April 2024 31 March 2025 

**From** 

## Section A                        Reference and administration details 


**----- Start of picture text -----**<br>
|||
|---|---|
|Charity name|The Institute for Aviation Research|
|Other names charity is known by|IAR|
|Registered charity number (if any)|1161611|
|——_|
|Charity's principal address|Roxhill Manor Farm|
|Roxhill Road|
|Marston Moretaine|
|Bedford|
|Postcode|MK43 0QG|

**----- End of picture text -----**<br>


**Registered charity number (if any)** 1161611 

**Names of the charity trustees who manage the charity** 


**----- Start of picture text -----**<br>
|||
|---|---|
|Dates acted if not for whole|Name of person (or body) entitled|
|Trustee name|Office (if any)|
|year|to appoint trustee (if any)|
|Prof Zheng Lei|11 May 2015 - Present|
|[Dr Cheung Kwok ]|11 May 2015 - Present|
|Law|
|Mrs Weihua Jiang|11 May 2015 - Present|
|[Dr John F ]|1 April 2016 - Present|
|O’Connell|
|=|
|Section B              Structure, governance and management|
|Description of the charity’s trusts|

**----- End of picture text -----**<br>


Constitution Type of governing document (eg. trust deed, constitution) 

How the charity is constituted (eg. trust, association, company) 

Charitable Incorporated Organisation 

The first three trustees are founding trustees, while the fourth was elected Trustee selection methods by the other trustees. (eg. appointed by, elected by) 

March **2012** 

**TAR** 

1 



## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**The Summary of the objects of the charity set out in its governing document** 

To advance education, for the benefit of the public, by promotion, on a non-political basis, of research into aviation and air transport ecosystem and to improve public understanding of aviation related issues through independent and rigorous research 

March **2012** 

**TAR** 

2 



The trustees have had due regard to the Charity Commission’s guidance on public benefit when planning and delivering the Institute’s activities. 

During the financial year, the Institute continued its research in aviation and published papers in leading academic journals. 

Members of the IAR team were also invited to deliver presentations at a range of seminars and professional events. 

In addition, the Institute engaged with external partners in preparation for a major event planned for 2026. 

**Summary of the main** During the reporting period, the Institute contributed to the advancement **activities undertaken for the** of education for the benefit of the public by promoting, on a non-political **public benefit in relation to** basis, independent and rigorous research into aviation and the air **these objects (include within** transport ecosystem, and by improving public understanding of aviation- **this section the statutory** related issues. **declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

Additional details of objectives and activities (Optional information) 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

March **2012** 

**TAR** 

3 



## Section D                      Achievements and performance 

**Summary of the main** During the year, IAR further strengthened its research activities and **achievements of the charity** international outreach, and published high-quality papers in leading **during the year** academic journals. 

March **2012** 

**TAR** 

4 



**Section E                    Financial review** IAR’s policy on reserves is to hold funds for working capital purposes and **Brief statement of the** as a contingency, should sufficient new funding not emerge. **charity’s policy on reserves Details of any funds materially** N.A. **in deficit** ~~a~~ **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: • the charity’s principal sources of funds (including any fundraising); • how expenditure has supported the key objectives of the charity; • investment policy and objectives including any ethical investment policy adopted. ~~_~~ 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s) Full name(s)** Zheng Lei **Position (eg Secretary, Chair,** Chair **etc) Date** 31 January 2026 

**Section F                     Other optional information** ~~___~~ 

March **2012** 

**TAR** 

5 



||**Institute for Aviation Research**|**Institute for Aviation Research**|**Institute for Aviation Research**||||**1161611**|**1161611**||||
|---|---|---|---|---|---|---|---|---|---|---|---|
||**Receipts andpayments accounts**|||||||||**CC16a**||
||**For the period**<br>**from**<br>~~ee~~||1/04/2024<br>~~ee~~||**To**|31/03/2025<br>~~ee~~||||||
|**Section A Receipts and payments**||||||||||||
||**Unrestricted**<br>**funds**||**Restricted**<br>**funds**||**Endowment**<br>**funds**|||**Total funds**||**Last year**||
||**to the nearest      £**|**to the nearest      £**|**to the nearest £**||**to the nearest £**|||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**||||||||||||
|Interests|**108**||**-**||**-**|**-**||**108**||**1,835**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
|~~**_Sub total_**~~|**-**<br> **108**||**-**<br>**-**||**-**<br>**-**|**-**<br>**-**||**-**<br>**108**||**-**<br>**1,835**||
|**A2 Asset and investment sales,**<br>**(see table).**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~**_Sub total_**~~**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total receipts_                       108**<br>**-**<br>**-**<br>**108**<br>**1,835**<br>~~S555~~||||||||||||
|**A3 Payments**||||||||||||
|Office equipment|**96**||**-**||**-**|**-**||**96**||**-**||
|Bank charges|**114**|||||||**114**||**-**||
|Website|**1,658**|||||||**1,658**||**-**||
|Research||||||||||**-**||
|||||||||||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
||**-**||**-**||**-**|**-**||**-**||**-**||
|**_Sub total_ **|**1,868**||**-**||**-**|**-**||**1,868**||**-**||
|**A4 Asset and investment**<br>**purchases, (see table)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Total payments_                    1,868**<br>**-**<br>**-**<br>**1,868**<br>**-**<br>**_Net of receipts/(payments)_**<br>**-                 1,760**<br>**-**<br>**-**<br>**-                 1,760**<br>**1,835**<br>**A5 Transfers between funds**<br>**-**<br>**-                           -**<br>**-**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**-                           -**<br>**-**<br>**-**<br>**_Cash funds this year end_**<br>**-                 1,760**<br>**-**<br>**-   -                 1,760**<br>**1,835**<br>~~SS55—~~<br>~~=SS~~<br>~~SS=~~||||||||||||



CCXX R1 accounts (SS) 

31/01/2026 

1 



|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**to nearest £**<br>**-                     1,760**<br>**-**<br>**-**<br>**1,835**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**75**<br>**-**<br>**-**<br>Cash funds this year end<br>Cash funds from previous years<br>**B1 Cash funds**<br>**Details**<br>**_Total cash funds_**<br>~~—~~|
|---|---|---|---|---|---|
||(agree balances with receipts and payments|(agree balances with receipts and payments||||
||account(s))|Agreement Error|OK||OK|
|||**Unrestricted**|**Restricted**||**Endowment**|
|||**funds**|**funds**||**funds**|
||**Details**|**to nearest £**|**to nearest £**||**to nearest £**|
|**B2 Other monetary assets**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~=—===~~|||||
||**Details**|**Fund to which**<br>**asset belongs**|**Cost (optional)**||**Current value**<br>**(optional)**|
|**B3 Investment assets**|||**-**||**-**|
||||**-**||**-**|
||||**-**||**-**|
||||**-**||**-**|
||||**-**||**-**|
||**Details**|**Fund to which**<br>**asset belongs**|**Cost (optional)**||**Current value**<br>**(optional)**|
|**B4 Assets retained for the**<br>**charity’s own use**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>~~====~~|||||
|||**Fund to which**|**Amount due**||**When due**|
|Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>CCXX R2 accounts (SS)|**liability relates**<br>**(optional)**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Date of<br>approval<br>31/01/2026<br>Print Name<br>ZhengLei<br>Signature<br>**Details**<br>2<br>31/01/2026<br>~~————~~|||||



